Diseases and Conditions

Sub-topics

Find more specific references for the following sub-topic(s):

1. Blood-Related Diseases
2. Cancer
3. Cardiovascular Diseases
4. Developmental Disabilities
5. Diabetes
6. Diarrheal Diseases
7. Helminthic Infections
8. HIV/AIDS
9. Infectious Diseases
10. Injuries and Violence
11. Malaria
12. Mental Disorders
13. Neurological Disorders
14. Noncommunicable Diseases
15. Respiratory Diseases
16. Sexually Transmitted Infections
17. TB
18. Tropical Diseases
19. Vaccine-Preventable Diseases

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 25. Acute Respiratory Infections in Children
2. 59. Adolescent Health Programs
3. 43. Air and Water Pollution: Burden and Strategies for Control
4. 47. Alcohol
5. 33. Cardiovascular Disease
6. 56. Community Health and Nutrition Programs
7. 69. Complementary and Alternative Medicine
8. 21. Conquering Malaria
9. 57. Contraception
10. 62. Control and Eradication
11. 15. Cost–Effectiveness Analysis for Priority Setting
12. 51. Cost–Effectiveness of Interventions for Musculoskeletal Conditions
13. 30. Diabetes: The Pandemic and Potential Solutions
14. 19. Diarrheal Diseases
15. 36. Diseases of the Kidney and the Urinary System
16. 55. Drug Resistance
17. 7. Economic Approaches to Valuing Global Health Research
18. 68. Emergency Medical Services
19. 72. Ensuring Supplies of Appropriate Drugs and Vaccines
20. 14. Ethical Issues in Resource Allocation, Research, and New Product Development
21. 12. Financing Health Systems in the 21st Century
22. 11. Fiscal Policies for Health Promotion and Disease Prevention
23. 10. Gender Differentials in Health
24. 64. General Primary Care
25. 29. Health Service Interventions for Cancer Control in Developing Countries
26. 71. Health Workers: Building and Motivating the Workforce
27. 24. Helminth Infections: Soil–Transmitted Helminth Infections and Schistosomiasis
28. 18. HIV/AIDS Prevention and Treatment
29. 48. Illicit Opiate Abuse
30. 8. Improving the Health of Populations: Lessons of Experience
31. 42. Indoor Air Pollution
32. 54. Information to Improve Decision Making for Health
33. 34. Inherited Disorders of Hemoglobin
34. 63. Integrated Management of the Sick Child
35. 40. Interpersonal Violence
36. 2. Intervention Cost–Effectiveness: Overview of Main Messages
37. 1. Investing in Health
38. 49. Learning and Developmental Disabilities
39. 50. Loss of Vision and Hearing
40. 26. Maternal and Perinatal Conditions
41. 31. Mental Disorders
42. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
43. 61. Natural Disaster Mitigation and Relief
44. 32. Neurological Disorders
45. 27. Newborn Survival
46. 60. Occupational Health
47. 38. Oral and Craniofacial Diseases and Disorders
48. 52. Pain Control for People with Cancer and AIDS
49. 44. Prevention of Chronic Disease by Means of Diet and Lifestyle Changes
50. 4. Priorities for Global Research and Development of Interventions
51. 6. Product Development Priorities
52. 53. Public Health Surveillance: A Tool for Targeting and Monitoring Intervention
53. 13. Recent Trends and Innovations in Development Assistance for Health
54. 35. Respiratory Diseases of Adults
55. 58. School–Based Health and Nutrition Programs
56. 5. Science and Technology for Disease Control: Past, Present, and Future
57. 17. Sexually Transmitted Infections
58. 37. Skin Diseases
59. 3. Strengthening Health Systems
60. 28. Stunting, Wasting, and Micronutrient Deficiency Disorders
61. 67. Surgery
62. 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight
63. 46. Tobacco Addiction
64. 23. Tropical Diseases Lacking Adequate Control Measures: Dengue, Leishmaniasis, and African Trypanosomiasis
65. 22. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy
66. 16. Tuberculosis
67. 39. Unintentional Injuries
68. 20. Vaccine–Preventable Diseases
69. 41. Water Supply, Sanitation, and Hygiene Promotion

Global Burden of Disease and Risk Factors

1. 4. Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors
2. 2. Demographic and Epidemiological Characteristics of Major Regions, 1990—2001
3. 6. Incorporating Deaths Near the Time of Birth into Estimates of the Global Burden of Disease
4. 1. Measuring the Global Burden of Disease and Risk Factors, 1990—2001
5. 5. Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates
6. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001

Priorities in Health

1. 1. Accomplishments, Challenges, and Priorities
2. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
3. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
4. 3. Cost–Effectiveness Analysis
5. 7. Pillars of the Health System
6. 6. Providing Interventions
7. 2. Success in Addressing Priorities
8. 8. The Way Forward: A Blueprint for Action

Chapter Presentations

Chapter 01. Investing in Health

1. The Burden of Disease, 2001
2. Under-Five Deaths from AIDS, Malaria, and Other Causes, Sub-Saharan Africa
3. Preventing and Treating HIV/AIDS: How much health will a million dollars buy?
4. Preventing and Treating Noncommunicable Diseases: How much health will a million dollars buy?
5. Cervical Cancer and Surgically Treatable Conditions: How much health will a million dollars buy?
6. Causes of Death, 2001

Chapter 02. Intervention Cost-Effectiveness: Overview of Main Messages

1. Cost-effectiveness of Interventions for Epidemic Tuberculosis in Low- and Middle-Income Countries
2. Cost-effectiveness of Interventions for Endemic Tuberculosis in Low- and Middle-Income Countries
3. Cost-effectiveness of Interventions for Malaria in Sub-Saharan Africa
4. Cost-effectiveness of Interventions for Diarrheal Disease in Low- and Middle-Income Countries
5. Neglected Low-Cost Opportunities in Sub-Saharan Africa: Cardiovascular Disease
6. Neglected Low-Cost Opportunities in Sub-Saharan Africa: HIV/AIDS and Maternal and Neonatal Care
7. Neglected Low-Cost Opportunities in Sub-Saharan Africa: Traffic Accidents, Surgical Services, and Emergency Care
8. Neglected Low-Cost Opportunities in Sub-Saharan Africa: Childhood Immunization, Malaria, and Childhood Illnesses
9. Neglected Low-Cost Opportunities in South Asia: HIV/AIDS and Tuberculosis
10. Neglected Low-Cost Opportunities in South Asia: Cardiovascular Disease
11. Neglected Low-Cost Opportunities in South Asia: Childhood Immunization, Lower Acute Respiratory Illness, and Maternal and Neonatal Care
12. Cost-effectiveness of Interventions for Neurological Disorders in Low- and Middle-Income Countries
13. Cost-effectiveness of Interventions for Mental Disorders in Low- and Middle-Income Countries
14. Cost-effectiveness of Interventions for Cardiovascular Disease and Diabetes in Low- and Middle-Income Countries
15. Cost-effectiveness of Interventions for HIV/AIDS Treatment in Low- and Middle-Income Countries
16. Cost-effectiveness of Interventions for HIV/AIDS Prevention in Low- and Middle-Income Countries

Chapter 04. Priorities for Global Research and Development of Interventions

1. Leading Causes of Disease Burden, by Select World Bank Region, 2001
2. Disease Burden Distribution, by Select World Bank Region, 2001
3. Disease Burden Distribution, by Select World Bank Region, 2001
4. Leading Causes of Disease Burden, by Select World Bank Region, 2001

Chapter 06. Product Development Priorities

1. Product Development for HIV/AIDS and TB, Public-Private Partnerships, 2004
2. Product Development for Tropical Diseases, Public-Private Partnerships, 2004

Chapter 17. Sexually Transmitted Infections

1. DALYs Averted by Preventing or Curing a Sexually Transmitted Infection

Chapter 20. Vaccine-Preventable Diseases

1. Cost per Deaths and Disability Adjusted Life Years Averted by Vaccination, 2001
2. Deaths Averted by Vaccination for Hib and Hepatitis B, 2001
3. Deaths Averted by Vaccination for Measles and Yellow Fever, 2001
4. Annual Cost per Fully Immunized Child for the Traditional Childhood Vaccines, By Region, 2001
5. Annual Cost per Fully Immunized Child for the Traditional Childhood Vaccines, By Immunization Strategy, 2001
6. Disability Adjusted Life Years Lost from Vaccine-Preventable Diseases, 2001
7. Deaths Averted by Vaccination for Diphtheria and Whooping Cough, 2001
8. Deaths Averted by Vaccination for Tetanus and Polio, 2001

Chapter 18. HIV/AIDS Prevention and Treatment

1. Cost-effectiveness of Voluntary Counseling and Testing for HIV/AIDS
2. Cost-effectiveness of Blood Safety Practices for HIV Prevention
3. Estimated Risk of HIV Transmission, By Type of Exposure
4. Cost-effectiveness of Peer-based Programs for Preventing HIV/AIDS
5. Cost-effectiveness of STI Treatment for Preventing HIV/AIDS
6. Cost-effectiveness of Antiretroviral Therapy for Preventing Mother-to-Child Transmission of HIV
7. Cost-effectiveness of Harm Reduction for Injecting Drug Users for HIV Prevention
8. HIV/AIDS Epidemic Profiles

Chapter 10. Gender Differentials in Health

1. Percentage of DALYs Resulting from Selected Conditions Specific to Women, 2001

Chapter 39. Unintentional Injuries

1. Interventions for Selected Unintentional Injuries in Low- and Middle-Income Countries
2. Deaths and DALYs Lost from Unintentional Injuries in Low- and Middle-Income Countries, 2001
3. Risk Factors for Road Traffic Injuries
4. Estimated Cost-effectiveness of Interventions Enforcing Traffic Regulations
5. Deaths from Unintentional Injuries in Low- and Middle-Income Countries, 2001
6. Estimated Cost-effectiveness of Installing Speed Bumps at Lethal Intersections

Chapter 09. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?

1. Effective Interventions to Achieve the HIV/AIDS MDG
2. Effective Interventions to Achieve the Tuberculosis MDG
3. Effective Interventions to Achieve the Malaria MDG

Chapter 21. Conquering Malaria

1. Estimated Deaths Due to Malaria, By Region, 2000
2. Disability Adjusted Life Years Lost Due to Malaria, By Region, 2000
3. Population at Risk for Malaria and Number of Malaria Cases, By Region, 2002
4. Estimated Deaths from Malaria in Children Under Age Five in Africa, 2000
5. Cost-effectiveness of Selected Malaria Interventions
6. Determinants of the Malaria Burden: Intrinsic and External Factors

Chapter 30. Diabetes: The Pandemic and Potential Solutions

1. Cost-effectiveness of Interventions for Preventing and Treating Diabetes in Developing Countries
2. Cost-effectiveness of Interventions for Preventing and Treating Diabetes in Developing Countries
3. Estimated Direct Medical Costs of Diabetes, By Region, 2003
4. Estimated Diabetes Deaths and DALYs Lost Among People Ages 20 to 79, By Region, 2001
5. Estimated Number of People Ages 20 to 79 with Diabetes, By Region, 2003 and 2025

Chapter 31. Mental Disorders

1. DALYs Averted by a Mental Health Care Package, By Region
2. Disease Burden of Selected Major Psychiatric Disorders, By Region, 2001
3. Costs of a Mental Health Care Package, By Region
4. Cost-effectiveness of a Mental Health Care Package, By Region

Chapter 47. Alcohol

1. Prevalence of High-Risk Drinking, By Gender, Age, and Region, 2000

Chapter 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight

1. Cost-effectiveness of Interventions for Cardiovascular Disease in Latin America and the Caribbean*
2. Global Cardiovascular Disease Burden Due to High Blood Pressure, Cholesterol, and Overweight
3. Cost-effectiveness of Interventions for Cardiovascular Disease in Africa*
4. Cost-effectiveness of Interventions for Cardiovascular Disease in Southeast Asia*
5. Cost-effectiveness of Interventions for Cardiovascular Disease in the Western Pacific*
6. Estimates of Cost-effectiveness of a Polypill for Cardiovascular Disease, By Region
7. Estimates of Cost-effectiveness of a Polypill for Cardiovascular Disease in India

Chapter 60. Occupational Health

1. Impact of an Immunization Safety Program at Health Centers in Burkina Faso, 2000 and 2003

Chapter 29. Health Service Interventions for Cancer Control in Developing Countries

1. Number of Deaths and DALYs Lost to Cancer, by Select World Bank Region, 2001 (in thousands)
2. Economic Outcomes of Once-in-a-Lifetime Cervical Cancer Screening Programs in Brazil
3. Economic Outcomes of Once-in-a-Lifetime Cervical Cancer Screening Programs in Madagascar
4. Economic Outcomes of Once-in-a-Lifetime Cervical Cancer Screening Programs in Zimbabwe
5. Number of Deaths and DALYs Lost to Cancer, by Select World Bank Region, 2001 (in thousands)

Chapter 22. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy

1. Control Strategies, Major Challenges, and Research Needs for Onchocerciasis
2. Control Strategies, Major Challenges, and Research Needs for Leprosy
3. Control Strategies, Major Challenges, and Research Needs for Lymphatic Filariasis
4. Cost per DALY Averted for Main Interventions for Select Targeted Tropical Diseases (US$)
5. Control Strategies, Major Challenges, and Research Needs for Chagas Disease
6. DALYs Lost, by Disease and Select World Bank Region (thousands)

Chapter 41. Water Supply, Sanitation, and Hygiene Promotion

1. Classification of Water-Related Infections
2. Reductions in Diarrhea Attributable to Water Supply, Sanitation, and Hygiene Promotion
3. Cost-effectiveness of Water Supply, Sanitation, and Hygiene Promotion